PDLI News Alert Pdl Biopharma (PDLI) 7.61 12/25/2014 12:50:4

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Pdl Biopharma (PDLI) 7.61 $PDLI

Biotech Stocks Technical Insight -- ARIAD Pharma, Geron, PDL BioPharma, Cytori Therapeutics, and Navidea Biopharma
PR Newswire - Thu Dec 18, 8:15AM CST
Investor-Edge has initiated coverage on the following equities: ARIAD Pharmaceuticals Inc. (NASDAQ: ARIA), Geron Corporation (NASDAQ: GERN), PDL BioPharma Inc. (NASDAQ: PDLI), Cytori Therapeutics Inc. (NASDAQ: CYTX), and Navidea Biopharmaceuticals Inc. (NYSE MKT: NAVB). Free research on these five companies can be accessed at: http://investor-edge.com/register. The US markets on Wednesday, December 17, 2014, surged as the Dow Jones Industrial Average finished at 17,356.87, up 1.69% and the NASDAQ Composite closed at 4,644.31, up 2.12%. The S&P 500 finished the session 2.04% higher at 2,012.89. During the trading session, all the ten sectors finished on a higher note. The S&P 500 Health Care Index ended the day at 791.66, up 1.90%, with the index advancing 6.28% in the previous three months. Register for your complimentary reports on these five stocks at:
NAVB: 2.00 (+0.02), CYTX: 0.48 (-0.01), GERN: 3.06 (+0.05), ARIA: 6.81 (+0.15), PDLI: 7.61 (unch)

PDL BioPharma declares $0.15 dividend
Seeking Alpha - at Seeking Alpha - Mon Dec 15, 3:10PM CST

PDLI: 7.61 (unch)

PDL BioPharma's Q4 Revenues to Rise Y/Y on Higher Royalties - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Dec 11, 3:10PM CST
PDL BioPharma (PDLI) estimates revenues to increase 41% from the year-ago period to roughly $158 million in the fourth quarter of 2014.
BIIB: 340.89 (+5.13), NVS: 93.91 (+0.66), PDLI: 7.61 (unch)

PDL BioPharma Provides Fourth Quarter 2014 Revenue Guidance of $158 Million
PR Newswire - Wed Dec 10, 3:02PM CST
PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced revenue guidance for the fourth quarter ending December 31, 2014, of approximately $158 million, as compared with actual revenue of $112 million for the fourth quarter of 2013, an approximate 41 percent increase.
PDLI: 7.61 (unch)

Is It Time to Buy This Growth Stock?
George Budwell, The Motley Fool - Motley Fool - Mon Dec 08, 8:43AM CST
Pharmaceutical stocks have absolutely soared amid the broader bull market. Shares of the specialist and generic drugmaker Actavis plc , for example, have more than tripled in value since 2012 alone:  Actavis' rocket-like trajectory, though,...
AGN: 210.12 (+0.95), VRX: 140.33 (-0.22), ACT: 254.20 (-1.68), CBST: 100.29 (-0.09), PFE: 31.42 (-0.03), PDLI: 7.61 (unch)

Danger Lurks in These 3 High-Yield Dividend Stocks
Motley Fool Staff - Motley Fool - Sun Dec 07, 9:09AM CST
Source: Flickr user  Shawn Carpenter . The allure of high-dividend yields is endlessly enticing, but often, high-dividend stocks come with higher-than-anticipated risks. In a bid to help identify high-dividend-paying companies that may stumble, we...
PETS: 14.23 (+0.08), GSK: 42.85 (+0.11), PDLI: 7.61 (unch)

PDL BioPharma Announces Conversion Rate Adjustments for Convertible Notes
PR Newswire - Thu Dec 04, 3:01PM CST
PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that the adjusted conversion rate for the:
PDLI: 7.61 (unch)

Dividend Dogs Of Healthcare: A 29.17% Advantage For The 5 Lowest Price High Yield Stocks
Fredrik Arnold - at Seeking Alpha - Thu Dec 04, 8:37AM CST

SNN: 38.18 (+0.14), VIVO: 16.68 (-0.02), PETS: 14.23 (+0.08), PFE: 31.42 (-0.03), MRK: 57.46 (+0.25), AZN: 70.44 (+0.26), THRX: 14.55 (+0.22), GSK: 42.85 (+0.11), SNY: 46.35 (+0.50), PDLI: 7.61 (unch)

5 Prime Dividend Dogs Of Healthcare Hound 11% To 45.4% November Upsides
Fredrik Arnold - at Seeking Alpha - Thu Dec 04, 2:40AM CST

KND: 18.21 (+0.11), VIVO: 16.68 (-0.02), PETS: 14.23 (+0.08), PFE: 31.42 (-0.03), GSK: 42.85 (+0.11), MSA: 53.48 (+0.79), HLS: 40.45 (+0.12), SEM: 14.67 (+0.27), PDLI: 7.61 (unch), SNN: 38.18 (+0.14), AZN: 70.44 (+0.26), MRK: 57.46 (+0.25), TRIB: 16.98 (-0.13), TEVA: 57.09 (+0.33), THRX: 14.55 (+0.22), SNY: 46.35 (+0.50)

Direct Flow Medical(R) Announces New Financing of $32 Million
Business Wire - Wed Dec 03, 7:01AM CST
Direct Flow Medical(R), Inc., a transcatheter heart valve innovator focused on improving patient outcomes, announced the closing of a new round of financing for the company totaling $32 million. Simultaneously, the company announced the appointment of Chris Richardson as its first Chief Commercial Officer to support global growth of the Direct Flow Medical Transcatheter Aortic Valve System.
PDLI: 7.61 (unch)

Insider Trading Alert - SPB, RH And PDLI Traded By Insiders
at The Street - Mon Dec 01, 9:30AM CST
Stocks with insider trader activity include SPB, RH and PDLI
RH: 96.97 (-0.16), SPB: 97.15 (-0.49), PDLI: 7.61 (unch)

3 Dangerous Dividend Stocks
Motley Fool Staff - Motley Fool - Mon Dec 01, 8:16AM CST
Yield. Danger ahead. You won't just see these warnings while on the road this holiday season -- they also relate to some dividend stocks. Investors can be enticed by high dividend yields, but sometimes the stocks themselves are dangerous picks. We...
FTR: 6.76 (-0.02), PSEC: 8.59 (-0.02), PDLI: 7.61 (unch)

InsiderInsights.com Daily Round Up 11/28/14: BBY, XOM, NES, FRAF
InsiderInsights - at Seeking Alpha - Sun Nov 30, 2:02AM CST

SIRO: 88.95 (+0.31), RH: 96.97 (-0.16), LPSB: 12.07 (-0.18), NES: 4.96 (-0.44), COTY: 20.67 (+0.40), XOM: 93.78 (-0.81), BBY: 38.89 (-0.80), SPB: 97.15 (-0.49), LIOX: 5.82 (+0.05), RM: 16.02 (+0.37), NEWM: 24.15 (+0.54), PDLI: 7.61 (unch), PDM: 19.03 (+0.01), PLUS: 72.63 (+0.09), WD: 17.63 (+0.28), HRG: 13.98 (-0.02), NMBL: 29.03 (+0.06)

3 Companies That Could Slash Their Dividends
Motley Fool Staff - Motley Fool - Mon Nov 24, 11:30AM CST
As investors, we like to see companies with strong dividends that increase over time. However, on occasion, companies are forced to cut their dividend due to a lack of cash flow, too high of a payout ratio, or even because of government regulators in...
FSC: 8.08 (+0.01), PFE: 31.42 (-0.03), FSAM: 13.35 (-0.07), PDLI: 7.61 (unch)

PDL BioPharma Earnings Review: 14 Days after Announcement Shares Down 0.9% (PDLI)
Comtex SmarTrend(R) - Mon Nov 24, 8:56AM CST
14 days ago, on November 10th, 2014, PDL BioPharma (NASDAQ DLI) reported its earnings. Analysts, on average, expected earnings of $0.56 per share on sales of $165.0 million. The company actually reported EPS of $0.61 on sales of $164.6 million, beating EPS estimates by $0.05 and matching revenue estimates. Since the company's report, shares of PDL BioPharma have fallen from $7.93 to $7.86, representing a loss of 0.9% in the past 14 days.
PDLI: 7.61 (unch)

This High-Yield Dividend Stock Screams Danger
Sean Williams, The Motley Fool - Motley Fool - Fri Nov 21, 7:45AM CST
Source: Flickr user Sunshinecity  When it comes to crafting the perfect retirement portfolio, I'd be remiss if I played down the critical role that dividends have in supplementing retirees' incomes and providing compounding gains over time for...
BIIB: 340.89 (+5.13), PDLI: 7.61 (unch)

PDL BioPharma Announces Successful Conclusion of Debt Financing Agreement with Durata Therapeutics
PR Newswire - Tue Nov 18, 6:00AM CST
PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that in connection with the acquisition of Durata Therapeutics, Inc. by Actavis, PDL has received approximately $42.7 million in connection with the termination of PDL's credit agreement with Durata, which included repayment of the full principal amount outstanding of $40 million, accrued interest, and prepayment and change of control premiums. In October 2013, PDL entered into a structured financing transaction with Durata in which PDL agreed to provide Durata with up to $70 million of debt financing with a five year term and in turn would receive interest on the principal amount outstanding and a security interest in substantially all of Durata's assets.
DRTX: 24.16 (+0.41), PDLI: 7.61 (unch)

PDL BioPharma Earnings In Retrospect: Down 1.8% in the Last 7 Days (PDLI)
Comtex SmarTrend(R) - Mon Nov 17, 1:06PM CST
A week ago on November 10th, 2014 PDL BioPharma (NASDAQ DLI) reported earnings and analysts, on average, expected earnings of $0.56 on sales of $165.0 million. The company actually reported EPS of $0.61 on sales of $164.6 million, beating EPS estimates by $0.05 and matching revenue estimates. Since the company's report, shares of PDL BioPharma have fallen from $7.93 to $7.79, representing a loss of 1.8% in the past 7 days.
PDLI: 7.61 (unch)

Buy-Rated Dividend Stocks In The Top 3: RGP, PDLI, SUI
at The Street - Mon Nov 17, 9:30AM CST
These 3 dividend stocks are rated a Buy by TheStreet
SUI: 62.18 (-0.08), RGP: 23.76 (+0.01), PDLI: 7.61 (unch)

PDL BIOPHARMA 72 HOUR DEADLINE ALERT: Approximately 72 Hours Remain; Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors of Deadline in Class Action Lawsuit Against PDL BioPharma, Inc. -- PDLI
GlobeNewswire - Fri Nov 14, 9:00PM CST
Kahn Swick & Foti, LLC ("KSF" and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with large financial interests that they have only until November 17, 2014 to file lead plaintiff applications in a securities class action lawsuit against PDL BioPharma, Inc. (Nasdaq DLI). Investor losses must relate to purchases of the Company's securities between November 6, 2013 and September 16, 2014. This action is pending in the United States District Court for the District of Nevada.
PDLI: 7.61 (unch)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

California Stone Ban Puts a Hidden Worker Toll in View

Updated Category News Views 42

Countertops are supposed to finish a kitchen, not quietly wreck the lungs of the people cutting them. Yet California's move toward prohibiting the fabrication and installation of artificial stone containing more than 1% crystalline silica puts an ugly, long-running occupational-health problem in plain sight. This is not a story that calls for chest-thumping market talk....

Continue Reading
Water Damage Coverage Has More Traps Than Homeowners Think

Updated Category News Views 29

A wet basement does not care one bit whether the water arrived dramatically or dripped in for months. That ugly distinction, though, can decide whether a homeowner has an insurance claim or a repair bill that lands with a thud. Kathy Thurmond-Edwards, an insurance expert in Memphis, Tennessee, lays out the dividing lines plainly: sudden pipe failures may be treated very...

Continue Reading
ACP's 1-for-4 Split Raises Price, Not Investor Value Yet

Updated Category News Views 68

Four ACP shares are about to become one, and the calculator crowd is liable to make a mountain out of a bookkeeping move. abrdn Income Credit Strategies Fund will execute a 1-for-4 reverse split before the opening bell on December 7, 2026. The quoted share price should rise by roughly four times, but the economic stake held by an investor does not magically get bigger...

Continue Reading
Surf City Seasons Put Vacation Rental Timing in Focus

Updated Category News Views 28

Summer’s Calendar Does the Talking School bells, not seagulls, appear to set the pace for Surf City’s rental market. Chris Rackley’s seasonal guide makes a pretty grounded point: the “best” time to visit Surf City, North Carolina, is not some universal magic week on a postcard. It depends on whether a traveler needs peak beach weather, wants elbow room, or...

Continue Reading
Home Nursing Plans Need Clarity Before the Next Crisis

Updated Category News Views 71

A medication change scribbled on a loose sheet can become a very long night. That is the unglamorous truth behind the discussion from Michael and Marsha Reda of Aurora Home Care in Williamsville, New York: long-term home nursing care depends on a plan people can actually follow when the household is tired, worried, and juggling too much. Their perspective, featured by...

Continue Reading
Cash Flow Discipline Is Where Business Growth Gets Real

Updated Category News Views 73

A full order book can still leave a company gasping at payroll. That is the unglamorous point behind the Nov. 20, 2026, HelloNation piece featuring Kimberly Furrh of Furrh & Associates PC in Lawton, Oklahoma. Owners love to talk about sales because sales are visible, flattering and easy to celebrate. Cash is less theatrical. It is also the thing that keeps the lights on...

Continue Reading
Tessera Delisting Leaves HLSQ in a Tougher Market Ahead

Updated Category News Views 116

November delivered a nasty little truth serum for Tessera Defense and Homeland Security: exchange status is not a cosmetic detail when the stock’s selling price has collapsed. On November 10, NYSE Regulation suspended trading in the company’s common shares on NYSE American and began delisting proceedings. By November 17, Tessera had a chance to request review by the...

Continue Reading
Rock Gate Buys Aviation Niche Player Blast Deflectors

Updated Category News Views 110

Jet exhaust is not glamorous, but somebody has to keep it from battering everything nearby. Rock Gate Partners’ acquisition of Blast Deflectors, Inc. puts money behind one of those stubbornly unsexy industrial niches where engineering credibility matters far more than a flashy sales pitch. The transaction closed October 16, 2026, and Northborne Partners announced...

Continue Reading
Rosalind Franklin University’s $23.8M Scholarship Win

Updated Category News Views 80

Twenty-three million dollars can disappear fast in graduate health education, which is exactly why Rosalind Franklin University’s campaign result deserves more than a polite round of applause. The university’s five-year Empowering Scholars effort closed in June 2026 with $23,836,272 raised, clearing its $20 million target by roughly 19%. In a world where institutions...

Continue Reading
Epic Blue Puts $50,000 of Marketing Work to Use Locally

Updated Category News Views 61

A $50,000 pile of donated know-how can look soft on a spreadsheet, until you remember how often a small nonprofit or early-stage outfit gets ignored because it cannot afford someone to sharpen its message. Epic Blue Marketing, a women-owned firm based in Jackson, Michigan, says it provided that amount in donated and reduced-rate marketing, communications and public...

Continue Reading

Top 5 Most Recently Viewed Articles

Thompson Thrift Secures Over $255 Million in New Funding

Updated Category News Views 303

Thompson Thrift Closes Major Funding Round for Multifamily Developments Thompson Thrift, a well-known real estate company, recently announced a significant achievement in closing its 2025 multifamily development fund. This limited partnership offering successfully raised over $255 million in capital commitments, exceeding its original target of $230 million. The funds aim...

Continue Reading
Buyglobal's Summer Sale Offers Outdoor Essentials and Deals

Updated Category News Views 25

Buyglobal's Summer Event: A Sunny Boost for Backyard Living Summer's rolling in, and Buyglobal is gearing up to help you transform those backyard spaces into your very own oasis. This ain't your average sale event—this is Buyglobal jumping headfirst into the season with a curated lineup that's all about making the most of the outdoors. They rolled out their...

Continue Reading
Tony Fadell Champions Plumerai's Tiny AI for Smart Homes

Updated Category News Views 201

Transforming Smart Home Security with Tiny AI In the realm of innovative technology, Tony Fadell, co-creator of the iPod and Nest founder, recognizes the groundbreaking work Plumerai is doing in the field of artificial intelligence. Their emphasis on Tiny AI technology is heralded as a pivotal shift that aims to democratize AI for everyday use, particularly in smart home...

Continue Reading
Glenn Pushis Takes Action: Sells $172K in Steel Dynamics Shares

Updated Category News Views 183

Understanding Insider Actions at Steel Dynamics A notable insider transaction has come to light involving Glenn Pushis, the Senior Vice President at Steel Dynamics (NASDAQ: STLD). This transaction was detailed through an SEC filing that disclosed a significant sell-off of shares worth $172,043. Details of the Sell-Transaction According to the Form 4 filing submitted to...

Continue Reading
SCF Partners Strengthens Market Position with New Acquisition

Updated Category News Views 228

SCF Partners' Strategic Acquisition of Newpark Fluids Systems SCF Partners is making waves with its recent acquisition of Newpark Fluids Systems, a well-respected name in the oil, gas, and geothermal fluids industry. This strategic decision underscores SCF's dedication to broadening its service offerings and expanding its market presence. Newpark Fluids Systems has built...

Continue Reading